Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Oct 31, 2016

Filed with the SEC on Dec 14, 2016 and accepted by EDGAR at Dec 14, 2016, 16:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-10-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2016-08-01 to 2016-10-31$1.0mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2016-05-01 to 2016-10-31$2.2mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-08-01 to 2016-10-31−$493.0kus-gaap:OperatingIncomeLoss
Operating income6 months2016-05-01 to 2016-10-31−$3.0mus-gaap:OperatingIncomeLoss
Income tax3 months2016-08-01 to 2016-10-31−$5.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2016-05-01 to 2016-10-31$9.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-08-01 to 2016-10-31−$504.0kus-gaap:NetIncomeLoss
Net income6 months2016-05-01 to 2016-10-31−$3.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-08-01 to 2016-10-31−$0.05us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2016-05-01 to 2016-10-31−$0.32us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2016-08-01 to 2016-10-31$116.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow6 months2016-05-01 to 2016-10-31−$2.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2016-05-01 to 2016-10-31$30.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-10-31$4.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-10-31$6.7mus-gaap:AssetsCurrent
Total assetsAt period end2016-10-31$8.0mus-gaap:Assets
Current liabilitiesAt period end2016-10-31$4.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-10-31$4.8mus-gaap:Liabilities
Shareholders' equityAt period end2016-10-31$3.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-16-022031. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.